This event has now been concluded, and you can find the slides here.
As an ESFRI landmark infrastructure, ELIXIR's role is to coordinate, integrate and sustain Europe's life science data resources. Since its establishment in December 2013, ELIXIR has grown to become one of the largest ESFRI research infrastructure in terms of membership by countries.
Through a series of talks during the day, ELIXIR will present examples of its achievements from the past ten years and describe the priorities for the next Scientific Programme (2024-2028). Talks from funders and collaborators will give a complementary perspective on developments relating to open science and research infrastructures. Confirmed speakers include:
- Dame Professor Janet Thornton, Emeritus Professor EMBL-EBI, ELIXIR Preparatory Phase Coordinator
- Anna Panagoupoulou, Director for ERA & Innovation, DG Research and Innovation, European Commission
- Anna Wetterbom, CEO ofthe Ragnar Söderberg Foundation
- Christine Chomienne, Horizon Europe Cancer Mission Board
- Jana Kolar, ESFRI Chair
- Mélodie Bernaux, DG SANTE, European Commission
- Michael Arentoft, Head of Unit, DG RTD, European Commission
- Natalia Jiménez Lozano, CGG and ELIXIR IAC
- Søren Brunak, Novo Nordisk Foundation, for Protein Research, University of Copenhagen
- Szymon Bielecki, DG CNECT, European Commission
- Ute Gunsenheimer, EOSC Association
Registration is by invitation only. For further information please email erika.balsyte [at] elixir-europe.org.